COVID-19 Impact on Global Valvular Heart Disease Treatment Market Size, Status and Forecast 2020-2026

August 2020 | 132 pages | ID: C08397544655EN
QYResearch

Abstracts

This report focuses on the global Valvular Heart Disease Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Valvular Heart Disease Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Abbott Laboratories
• B. Braun Melsungen AG
• Boston Scientific Corp.
• Medtronic
• CryoLife Inc.
• Edwards Lifesciences Corporation
• LivaNova PLC
• Neovasc Inc.
• Micro Interventional Devices
• Symetis SA
• Jenavalve Technology
• TTK Healthcare Limited
• Colibri Heart Valve
• Lepu Medical Technology Co.
• Braile Biom?dica

Market segment by Type, the product can be split into

• Cardiac Catheterization
• Electrocardiogram (ECG)
• Chest X-Ray
• Stress Test
• Others

Market segment by Application, split into

• Hospital & Clinics
• Ambulatory Surgical Centers
• Research Institutes

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Valvular Heart Disease Treatment status, future forecast, growth opportunity, key market and key players.
• To present the Valvular Heart Disease Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Valvular Heart Disease Treatment are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Valvular Heart Disease Treatment Revenue
1.4 Market Analysis by Type
  1.4.1 Global Valvular Heart Disease Treatment Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Cardiac Catheterization
  1.4.3 Electrocardiogram (ECG)
  1.4.4 Chest X-Ray
  1.4.5 Stress Test
  1.4.6 Others
1.5 Market by Application
  1.5.1 Global Valvular Heart Disease Treatment Market Share by Application: 2020 VS 2026
  1.5.2 Hospital & Clinics
  1.5.3 Ambulatory Surgical Centers
  1.5.4 Research Institutes
1.6 Coronavirus Disease 2019 (Covid-19): Valvular Heart Disease Treatment Industry Impact
  1.6.1 How the Covid-19 is Affecting the Valvular Heart Disease Treatment Industry
    1.6.1.1 Valvular Heart Disease Treatment Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Valvular Heart Disease Treatment Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Valvular Heart Disease Treatment Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Valvular Heart Disease Treatment Market Perspective (2015-2026)
2.2 Valvular Heart Disease Treatment Growth Trends by Regions
  2.2.1 Valvular Heart Disease Treatment Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Valvular Heart Disease Treatment Historic Market Share by Regions (2015-2020)
  2.2.3 Valvular Heart Disease Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Valvular Heart Disease Treatment Market Growth Strategy
  2.3.6 Primary Interviews with Key Valvular Heart Disease Treatment Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Valvular Heart Disease Treatment Players by Market Size
  3.1.1 Global Top Valvular Heart Disease Treatment Players by Revenue (2015-2020)
  3.1.2 Global Valvular Heart Disease Treatment Revenue Market Share by Players (2015-2020)
  3.1.3 Global Valvular Heart Disease Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Valvular Heart Disease Treatment Market Concentration Ratio
  3.2.1 Global Valvular Heart Disease Treatment Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Valvular Heart Disease Treatment Revenue in 2019
3.3 Valvular Heart Disease Treatment Key Players Head office and Area Served
3.4 Key Players Valvular Heart Disease Treatment Product Solution and Service
3.5 Date of Enter into Valvular Heart Disease Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Valvular Heart Disease Treatment Historic Market Size by Type (2015-2020)
4.2 Global Valvular Heart Disease Treatment Forecasted Market Size by Type (2021-2026)

5 VALVULAR HEART DISEASE TREATMENT BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Valvular Heart Disease Treatment Market Size by Application (2015-2020)
5.2 Global Valvular Heart Disease Treatment Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Valvular Heart Disease Treatment Market Size (2015-2020)
6.2 Valvular Heart Disease Treatment Key Players in North America (2019-2020)
6.3 North America Valvular Heart Disease Treatment Market Size by Type (2015-2020)
6.4 North America Valvular Heart Disease Treatment Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Valvular Heart Disease Treatment Market Size (2015-2020)
7.2 Valvular Heart Disease Treatment Key Players in Europe (2019-2020)
7.3 Europe Valvular Heart Disease Treatment Market Size by Type (2015-2020)
7.4 Europe Valvular Heart Disease Treatment Market Size by Application (2015-2020)

8 CHINA

8.1 China Valvular Heart Disease Treatment Market Size (2015-2020)
8.2 Valvular Heart Disease Treatment Key Players in China (2019-2020)
8.3 China Valvular Heart Disease Treatment Market Size by Type (2015-2020)
8.4 China Valvular Heart Disease Treatment Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Valvular Heart Disease Treatment Market Size (2015-2020)
9.2 Valvular Heart Disease Treatment Key Players in Japan (2019-2020)
9.3 Japan Valvular Heart Disease Treatment Market Size by Type (2015-2020)
9.4 Japan Valvular Heart Disease Treatment Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Valvular Heart Disease Treatment Market Size (2015-2020)
10.2 Valvular Heart Disease Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Valvular Heart Disease Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Valvular Heart Disease Treatment Market Size by Application (2015-2020)

11 INDIA

11.1 India Valvular Heart Disease Treatment Market Size (2015-2020)
11.2 Valvular Heart Disease Treatment Key Players in India (2019-2020)
11.3 India Valvular Heart Disease Treatment Market Size by Type (2015-2020)
11.4 India Valvular Heart Disease Treatment Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Valvular Heart Disease Treatment Market Size (2015-2020)
12.2 Valvular Heart Disease Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Valvular Heart Disease Treatment Market Size by Type (2015-2020)
12.4 Central & South America Valvular Heart Disease Treatment Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Abbott Laboratories
  13.1.1 Abbott Laboratories Company Details
  13.1.2 Abbott Laboratories Business Overview and Its Total Revenue
  13.1.3 Abbott Laboratories Valvular Heart Disease Treatment Introduction
  13.1.4 Abbott Laboratories Revenue in Valvular Heart Disease Treatment Business (2015-2020))
  13.1.5 Abbott Laboratories Recent Development
13.2 B. Braun Melsungen AG
  13.2.1 B. Braun Melsungen AG Company Details
  13.2.2 B. Braun Melsungen AG Business Overview and Its Total Revenue
  13.2.3 B. Braun Melsungen AG Valvular Heart Disease Treatment Introduction
  13.2.4 B. Braun Melsungen AG Revenue in Valvular Heart Disease Treatment Business (2015-2020)
  13.2.5 B. Braun Melsungen AG Recent Development
13.3 Boston Scientific Corp.
  13.3.1 Boston Scientific Corp. Company Details
  13.3.2 Boston Scientific Corp. Business Overview and Its Total Revenue
  13.3.3 Boston Scientific Corp. Valvular Heart Disease Treatment Introduction
  13.3.4 Boston Scientific Corp. Revenue in Valvular Heart Disease Treatment Business (2015-2020)
  13.3.5 Boston Scientific Corp. Recent Development
13.4 Medtronic
  13.4.1 Medtronic Company Details
  13.4.2 Medtronic Business Overview and Its Total Revenue
  13.4.3 Medtronic Valvular Heart Disease Treatment Introduction
  13.4.4 Medtronic Revenue in Valvular Heart Disease Treatment Business (2015-2020)
  13.4.5 Medtronic Recent Development
13.5 CryoLife Inc.
  13.5.1 CryoLife Inc. Company Details
  13.5.2 CryoLife Inc. Business Overview and Its Total Revenue
  13.5.3 CryoLife Inc. Valvular Heart Disease Treatment Introduction
  13.5.4 CryoLife Inc. Revenue in Valvular Heart Disease Treatment Business (2015-2020)
  13.5.5 CryoLife Inc. Recent Development
13.6 Edwards Lifesciences Corporation
  13.6.1 Edwards Lifesciences Corporation Company Details
  13.6.2 Edwards Lifesciences Corporation Business Overview and Its Total Revenue
  13.6.3 Edwards Lifesciences Corporation Valvular Heart Disease Treatment Introduction
  13.6.4 Edwards Lifesciences Corporation Revenue in Valvular Heart Disease Treatment Business (2015-2020)
  13.6.5 Edwards Lifesciences Corporation Recent Development
13.7 LivaNova PLC
  13.7.1 LivaNova PLC Company Details
  13.7.2 LivaNova PLC Business Overview and Its Total Revenue
  13.7.3 LivaNova PLC Valvular Heart Disease Treatment Introduction
  13.7.4 LivaNova PLC Revenue in Valvular Heart Disease Treatment Business (2015-2020)
  13.7.5 LivaNova PLC Recent Development
13.8 Neovasc Inc.
  13.8.1 Neovasc Inc. Company Details
  13.8.2 Neovasc Inc. Business Overview and Its Total Revenue
  13.8.3 Neovasc Inc. Valvular Heart Disease Treatment Introduction
  13.8.4 Neovasc Inc. Revenue in Valvular Heart Disease Treatment Business (2015-2020)
  13.8.5 Neovasc Inc. Recent Development
13.9 Micro Interventional Devices
  13.9.1 Micro Interventional Devices Company Details
  13.9.2 Micro Interventional Devices Business Overview and Its Total Revenue
  13.9.3 Micro Interventional Devices Valvular Heart Disease Treatment Introduction
  13.9.4 Micro Interventional Devices Revenue in Valvular Heart Disease Treatment Business (2015-2020)
  13.9.5 Micro Interventional Devices Recent Development
13.10 Symetis SA
  13.10.1 Symetis SA Company Details
  13.10.2 Symetis SA Business Overview and Its Total Revenue
  13.10.3 Symetis SA Valvular Heart Disease Treatment Introduction
  13.10.4 Symetis SA Revenue in Valvular Heart Disease Treatment Business (2015-2020)
  13.10.5 Symetis SA Recent Development
13.11 Jenavalve Technology
  10.11.1 Jenavalve Technology Company Details
  10.11.2 Jenavalve Technology Business Overview and Its Total Revenue
  10.11.3 Jenavalve Technology Valvular Heart Disease Treatment Introduction
  10.11.4 Jenavalve Technology Revenue in Valvular Heart Disease Treatment Business (2015-2020)
  10.11.5 Jenavalve Technology Recent Development
13.12 TTK Healthcare Limited
  10.12.1 TTK Healthcare Limited Company Details
  10.12.2 TTK Healthcare Limited Business Overview and Its Total Revenue
  10.12.3 TTK Healthcare Limited Valvular Heart Disease Treatment Introduction
  10.12.4 TTK Healthcare Limited Revenue in Valvular Heart Disease Treatment Business (2015-2020)
  10.12.5 TTK Healthcare Limited Recent Development
13.13 Colibri Heart Valve
  10.13.1 Colibri Heart Valve Company Details
  10.13.2 Colibri Heart Valve Business Overview and Its Total Revenue
  10.13.3 Colibri Heart Valve Valvular Heart Disease Treatment Introduction
  10.13.4 Colibri Heart Valve Revenue in Valvular Heart Disease Treatment Business (2015-2020)
  10.13.5 Colibri Heart Valve Recent Development
13.14 Lepu Medical Technology Co.
  10.14.1 Lepu Medical Technology Co. Company Details
  10.14.2 Lepu Medical Technology Co. Business Overview and Its Total Revenue
  10.14.3 Lepu Medical Technology Co. Valvular Heart Disease Treatment Introduction
  10.14.4 Lepu Medical Technology Co. Revenue in Valvular Heart Disease Treatment Business (2015-2020)
  10.14.5 Lepu Medical Technology Co. Recent Development
13.15 Braile Biom?dica
  10.15.1 Braile Biom?dica Company Details
  10.15.2 Braile Biom?dica Business Overview and Its Total Revenue
  10.15.3 Braile Biom?dica Valvular Heart Disease Treatment Introduction
  10.15.4 Braile Biom?dica Revenue in Valvular Heart Disease Treatment Business (2015-2020)
  10.15.5 Braile Biom?dica Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Valvular Heart Disease Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Valvular Heart Disease Treatment Revenue
Table 3. Ranking of Global Top Valvular Heart Disease Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Valvular Heart Disease Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Cardiac Catheterization
Table 6. Key Players of Electrocardiogram (ECG)
Table 7. Key Players of Chest X-Ray
Table 8. Key Players of Stress Test
Table 9. Key Players of Others
Table 10. COVID-19 Impact Global Market: (Four Valvular Heart Disease Treatment Market Size Forecast Scenarios)
Table 11. Opportunities and Trends for Valvular Heart Disease Treatment Players in the COVID-19 Landscape
Table 12. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 13. Key Regions/Countries Measures against Covid-19 Impact
Table 14. Proposal for Valvular Heart Disease Treatment Players to Combat Covid-19 Impact
Table 15. Global Valvular Heart Disease Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 16. Global Valvular Heart Disease Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 17. Global Valvular Heart Disease Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 18. Global Valvular Heart Disease Treatment Market Share by Regions (2015-2020)
Table 19. Global Valvular Heart Disease Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 20. Global Valvular Heart Disease Treatment Market Share by Regions (2021-2026)
Table 21. Market Top Trends
Table 22. Key Drivers: Impact Analysis
Table 23. Key Challenges
Table 24. Valvular Heart Disease Treatment Market Growth Strategy
Table 25. Main Points Interviewed from Key Valvular Heart Disease Treatment Players
Table 26. Global Valvular Heart Disease Treatment Revenue by Players (2015-2020) (Million US$)
Table 27. Global Valvular Heart Disease Treatment Market Share by Players (2015-2020)
Table 28. Global Top Valvular Heart Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Valvular Heart Disease Treatment as of 2019)
Table 29. Global Valvular Heart Disease Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 30. Key Players Headquarters and Area Served
Table 31. Key Players Valvular Heart Disease Treatment Product Solution and Service
Table 32. Date of Enter into Valvular Heart Disease Treatment Market
Table 33. Mergers & Acquisitions, Expansion Plans
Table 34. Global Valvular Heart Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 35. Global Valvular Heart Disease Treatment Market Size Share by Type (2015-2020)
Table 36. Global Valvular Heart Disease Treatment Revenue Market Share by Type (2021-2026)
Table 37. Global Valvular Heart Disease Treatment Market Size Share by Application (2015-2020)
Table 38. Global Valvular Heart Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 39. Global Valvular Heart Disease Treatment Market Size Share by Application (2021-2026)
Table 40. North America Key Players Valvular Heart Disease Treatment Revenue (2019-2020) (Million US$)
Table 41. North America Key Players Valvular Heart Disease Treatment Market Share (2019-2020)
Table 42. North America Valvular Heart Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 43. North America Valvular Heart Disease Treatment Market Share by Type (2015-2020)
Table 44. North America Valvular Heart Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 45. North America Valvular Heart Disease Treatment Market Share by Application (2015-2020)
Table 46. Europe Key Players Valvular Heart Disease Treatment Revenue (2019-2020) (Million US$)
Table 47. Europe Key Players Valvular Heart Disease Treatment Market Share (2019-2020)
Table 48. Europe Valvular Heart Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 49. Europe Valvular Heart Disease Treatment Market Share by Type (2015-2020)
Table 50. Europe Valvular Heart Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 51. Europe Valvular Heart Disease Treatment Market Share by Application (2015-2020)
Table 52. China Key Players Valvular Heart Disease Treatment Revenue (2019-2020) (Million US$)
Table 53. China Key Players Valvular Heart Disease Treatment Market Share (2019-2020)
Table 54. China Valvular Heart Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 55. China Valvular Heart Disease Treatment Market Share by Type (2015-2020)
Table 56. China Valvular Heart Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 57. China Valvular Heart Disease Treatment Market Share by Application (2015-2020)
Table 58. Japan Key Players Valvular Heart Disease Treatment Revenue (2019-2020) (Million US$)
Table 59. Japan Key Players Valvular Heart Disease Treatment Market Share (2019-2020)
Table 60. Japan Valvular Heart Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 61. Japan Valvular Heart Disease Treatment Market Share by Type (2015-2020)
Table 62. Japan Valvular Heart Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 63. Japan Valvular Heart Disease Treatment Market Share by Application (2015-2020)
Table 64. Southeast Asia Key Players Valvular Heart Disease Treatment Revenue (2019-2020) (Million US$)
Table 65. Southeast Asia Key Players Valvular Heart Disease Treatment Market Share (2019-2020)
Table 66. Southeast Asia Valvular Heart Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 67. Southeast Asia Valvular Heart Disease Treatment Market Share by Type (2015-2020)
Table 68. Southeast Asia Valvular Heart Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 69. Southeast Asia Valvular Heart Disease Treatment Market Share by Application (2015-2020)
Table 70. India Key Players Valvular Heart Disease Treatment Revenue (2019-2020) (Million US$)
Table 71. India Key Players Valvular Heart Disease Treatment Market Share (2019-2020)
Table 72. India Valvular Heart Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 73. India Valvular Heart Disease Treatment Market Share by Type (2015-2020)
Table 74. India Valvular Heart Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 75. India Valvular Heart Disease Treatment Market Share by Application (2015-2020)
Table 76. Central & South America Key Players Valvular Heart Disease Treatment Revenue (2019-2020) (Million US$)
Table 77. Central & South America Key Players Valvular Heart Disease Treatment Market Share (2019-2020)
Table 78. Central & South America Valvular Heart Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 79. Central & South America Valvular Heart Disease Treatment Market Share by Type (2015-2020)
Table 80. Central & South America Valvular Heart Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 81. Central & South America Valvular Heart Disease Treatment Market Share by Application (2015-2020)
Table 82. Abbott Laboratories Company Details
Table 83. Abbott Laboratories Business Overview
Table 84. Abbott Laboratories Product
Table 85. Abbott Laboratories Revenue in Valvular Heart Disease Treatment Business (2015-2020) (Million US$)
Table 86. Abbott Laboratories Recent Development
Table 87. B. Braun Melsungen AG Company Details
Table 88. B. Braun Melsungen AG Business Overview
Table 89. B. Braun Melsungen AG Product
Table 90. B. Braun Melsungen AG Revenue in Valvular Heart Disease Treatment Business (2015-2020) (Million US$)
Table 91. B. Braun Melsungen AG Recent Development
Table 92. Boston Scientific Corp. Company Details
Table 93. Boston Scientific Corp. Business Overview
Table 94. Boston Scientific Corp. Product
Table 95. Boston Scientific Corp. Revenue in Valvular Heart Disease Treatment Business (2015-2020) (Million US$)
Table 96. Boston Scientific Corp. Recent Development
Table 97. Medtronic Company Details
Table 98. Medtronic Business Overview
Table 99. Medtronic Product
Table 100. Medtronic Revenue in Valvular Heart Disease Treatment Business (2015-2020) (Million US$)
Table 101. Medtronic Recent Development
Table 102. CryoLife Inc. Company Details
Table 103. CryoLife Inc. Business Overview
Table 104. CryoLife Inc. Product
Table 105. CryoLife Inc. Revenue in Valvular Heart Disease Treatment Business (2015-2020) (Million US$)
Table 106. CryoLife Inc. Recent Development
Table 107. Edwards Lifesciences Corporation Company Details
Table 108. Edwards Lifesciences Corporation Business Overview
Table 109. Edwards Lifesciences Corporation Product
Table 110. Edwards Lifesciences Corporation Revenue in Valvular Heart Disease Treatment Business (2015-2020) (Million US$)
Table 111. Edwards Lifesciences Corporation Recent Development
Table 112. LivaNova PLC Company Details
Table 113. LivaNova PLC Business Overview
Table 114. LivaNova PLC Product
Table 115. LivaNova PLC Revenue in Valvular Heart Disease Treatment Business (2015-2020) (Million US$)
Table 116. LivaNova PLC Recent Development
Table 117. Neovasc Inc. Business Overview
Table 118. Neovasc Inc. Product
Table 119. Neovasc Inc. Company Details
Table 120. Neovasc Inc. Revenue in Valvular Heart Disease Treatment Business (2015-2020) (Million US$)
Table 121. Neovasc Inc. Recent Development
Table 122. Micro Interventional Devices Company Details
Table 123. Micro Interventional Devices Business Overview
Table 124. Micro Interventional Devices Product
Table 125. Micro Interventional Devices Revenue in Valvular Heart Disease Treatment Business (2015-2020) (Million US$)
Table 126. Micro Interventional Devices Recent Development
Table 127. Symetis SA Company Details
Table 128. Symetis SA Business Overview
Table 129. Symetis SA Product
Table 130. Symetis SA Revenue in Valvular Heart Disease Treatment Business (2015-2020) (Million US$)
Table 131. Symetis SA Recent Development
Table 132. Jenavalve Technology Company Details
Table 133. Jenavalve Technology Business Overview
Table 134. Jenavalve Technology Product
Table 135. Jenavalve Technology Revenue in Valvular Heart Disease Treatment Business (2015-2020) (Million US$)
Table 136. Jenavalve Technology Recent Development
Table 137. TTK Healthcare Limited Company Details
Table 138. TTK Healthcare Limited Business Overview
Table 139. TTK Healthcare Limited Product
Table 140. TTK Healthcare Limited Revenue in Valvular Heart Disease Treatment Business (2015-2020) (Million US$)
Table 141. TTK Healthcare Limited Recent Development
Table 142. Colibri Heart Valve Company Details
Table 143. Colibri Heart Valve Business Overview
Table 144. Colibri Heart Valve Product
Table 145. Colibri Heart Valve Revenue in Valvular Heart Disease Treatment Business (2015-2020) (Million US$)
Table 146. Colibri Heart Valve Recent Development
Table 147. Lepu Medical Technology Co. Company Details
Table 148. Lepu Medical Technology Co. Business Overview
Table 149. Lepu Medical Technology Co. Product
Table 150. Lepu Medical Technology Co. Revenue in Valvular Heart Disease Treatment Business (2015-2020) (Million US$)
Table 151. Lepu Medical Technology Co. Recent Development
Table 152. Braile Biom?dica Company Details
Table 153. Braile Biom?dica Business Overview
Table 154. Braile Biom?dica Product
Table 155. Braile Biom?dica Revenue in Valvular Heart Disease Treatment Business (2015-2020) (Million US$)
Table 156. Braile Biom?dica Recent Development
Table 157. Research Programs/Design for This Report
Table 158. Key Data Information from Secondary Sources
Table 159. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Valvular Heart Disease Treatment Market Share by Type: 2020 VS 2026
Figure 2. Cardiac Catheterization Features
Figure 3. Electrocardiogram (ECG) Features
Figure 4. Chest X-Ray Features
Figure 5. Stress Test Features
Figure 6. Others Features
Figure 7. Global Valvular Heart Disease Treatment Market Share by Application: 2020 VS 2026
Figure 8. Hospital & Clinics Case Studies
Figure 9. Ambulatory Surgical Centers Case Studies
Figure 10. Research Institutes Case Studies
Figure 11. Valvular Heart Disease Treatment Report Years Considered
Figure 12. Global Valvular Heart Disease Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Valvular Heart Disease Treatment Market Share by Regions: 2020 VS 2026
Figure 14. Global Valvular Heart Disease Treatment Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Valvular Heart Disease Treatment Market Share by Players in 2019
Figure 17. Global Top Valvular Heart Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Valvular Heart Disease Treatment as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Valvular Heart Disease Treatment Revenue in 2019
Figure 19. North America Valvular Heart Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Valvular Heart Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Valvular Heart Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Valvular Heart Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Valvular Heart Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Valvular Heart Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Valvular Heart Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Abbott Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Abbott Laboratories Revenue Growth Rate in Valvular Heart Disease Treatment Business (2015-2020)
Figure 28. B. Braun Melsungen AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. B. Braun Melsungen AG Revenue Growth Rate in Valvular Heart Disease Treatment Business (2015-2020)
Figure 30. Boston Scientific Corp. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Boston Scientific Corp. Revenue Growth Rate in Valvular Heart Disease Treatment Business (2015-2020)
Figure 32. Medtronic Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Medtronic Revenue Growth Rate in Valvular Heart Disease Treatment Business (2015-2020)
Figure 34. CryoLife Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. CryoLife Inc. Revenue Growth Rate in Valvular Heart Disease Treatment Business (2015-2020)
Figure 36. Edwards Lifesciences Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Edwards Lifesciences Corporation Revenue Growth Rate in Valvular Heart Disease Treatment Business (2015-2020)
Figure 38. LivaNova PLC Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. LivaNova PLC Revenue Growth Rate in Valvular Heart Disease Treatment Business (2015-2020)
Figure 40. Neovasc Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Neovasc Inc. Revenue Growth Rate in Valvular Heart Disease Treatment Business (2015-2020)
Figure 42. Micro Interventional Devices Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Micro Interventional Devices Revenue Growth Rate in Valvular Heart Disease Treatment Business (2015-2020)
Figure 44. Symetis SA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. Symetis SA Revenue Growth Rate in Valvular Heart Disease Treatment Business (2015-2020)
Figure 46. Jenavalve Technology Total Revenue (US$ Million): 2019 Compared with 2018
Figure 47. Jenavalve Technology Revenue Growth Rate in Valvular Heart Disease Treatment Business (2015-2020)
Figure 48. TTK Healthcare Limited Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. TTK Healthcare Limited Revenue Growth Rate in Valvular Heart Disease Treatment Business (2015-2020)
Figure 50. Colibri Heart Valve Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Colibri Heart Valve Revenue Growth Rate in Valvular Heart Disease Treatment Business (2015-2020)
Figure 52. Lepu Medical Technology Co. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Lepu Medical Technology Co. Revenue Growth Rate in Valvular Heart Disease Treatment Business (2015-2020)
Figure 54. Braile Biom?dica Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Braile Biom?dica Revenue Growth Rate in Valvular Heart Disease Treatment Business (2015-2020)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed